Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1967 1
1969 2
1970 1
1972 1
1974 1
1975 4
1977 1
1978 5
1980 4
1981 3
1982 6
1983 5
1984 10
1985 6
1986 8
1987 9
1988 5
1989 6
1990 16
1991 15
1992 17
1993 13
1994 15
1995 21
1996 18
1997 24
1998 21
1999 20
2000 24
2001 35
2002 29
2003 35
2004 32
2005 44
2006 48
2007 47
2008 58
2009 52
2010 60
2011 77
2012 60
2013 82
2014 99
2015 84
2016 111
2017 132
2018 131
2019 127
2020 177
2021 184
2022 213
2023 163
2024 75

Text availability

Article attribute

Article type

Publication date

Search Results

2,186 results

Results by year

Filters applied: . Clear all
Page 1
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.
Teachey DT, Devidas M, Wood BL, Chen Z, Hayashi RJ, Hermiston ML, Annett RD, Archer JH, Asselin BL, August KJ, Cho SY, Dunsmore KP, Fisher BT, Freedman JL, Galardy PJ, Harker-Murray P, Horton TM, Jaju AI, Lam A, Messinger YH, Miles RR, Okada M, Patel SI, Schafer ES, Schechter T, Singh N, Steele AC, Sulis ML, Vargas SL, Winter SS, Wood C, Zweidler-McKay P, Bollard CM, Loh ML, Hunger SP, Raetz EA. Teachey DT, et al. Among authors: lam a. J Clin Oncol. 2022 Jul 1;40(19):2106-2118. doi: 10.1200/JCO.21.02678. Epub 2022 Mar 10. J Clin Oncol. 2022. PMID: 35271306 Free PMC article. Clinical Trial.
Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial.
Sutharsan S, McKone EF, Downey DG, Duckers J, MacGregor G, Tullis E, Van Braeckel E, Wainwright CE, Watson D, Ahluwalia N, Bruinsma BG, Harris C, Lam AP, Lou Y, Moskowitz SM, Tian S, Yuan J, Waltz D, Mall MA; VX18-445-109 study group. Sutharsan S, et al. Among authors: lam ap. Lancet Respir Med. 2022 Mar;10(3):267-277. doi: 10.1016/S2213-2600(21)00454-9. Epub 2021 Dec 20. Lancet Respir Med. 2022. PMID: 34942085 Clinical Trial.
Macrophages promote anti-androgen resistance in prostate cancer bone disease.
Li XF, Selli C, Zhou HL, Cao J, Wu S, Ma RY, Lu Y, Zhang CB, Xun B, Lam AD, Pang XC, Fernando A, Zhang Z, Unciti-Broceta A, Carragher NO, Ramachandran P, Henderson NC, Sun LL, Hu HY, Li GB, Sawyers C, Qian BZ. Li XF, et al. Among authors: lam ad. J Exp Med. 2023 Apr 3;220(4):e20221007. doi: 10.1084/jem.20221007. Epub 2023 Feb 7. J Exp Med. 2023. PMID: 36749798 Free PMC article.
[No title available]
Jonuscheit S, Lam AK, Schmid KL, Flanagan JG, Martin R, Troilo D. Jonuscheit S, et al. Among authors: lam ak. Ophthalmic Physiol Opt. 2021 May;41(3):632. doi: 10.1111/opo.12803. Epub 2021 Mar 20. Ophthalmic Physiol Opt. 2021. PMID: 33742726 No abstract available.
Cutaneous lymphoma in a Dachshund.
Lam A. Lam A. Can Vet J. 2021 Jul;62(7):771-774. Can Vet J. 2021. PMID: 34219791 Free PMC article. No abstract available.
2,186 results